References
- Arora S., Anubhuti W. (2006). Role of neuropeptides in appetite regulation and obesity -areview. Neuropeptides, 40: 375-401.
- Barnikol - Watanabe S., Gross N.A., G ötz H., Henkel T., Karabinos A., Krat - zin H., Barnikol H.U., Hilschmann N. (1994). Human protein NEFA,anovel DNA binding/ EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the c DNA, isolation and characterization of the protein. Biol. Chem. Hoppe Seyler, 375: 497-512.
- Berthoud H.R., Neuhuber W.L. (2000). Functional and chemical anatomy of the afferent vagal system. Auton Neurosci., 85: 1-17.
- Bonnet M.S., Pecchi E., Trouslard J., Jean A., Dallaporta M., Troadec J.D. (2009). Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J. Neuroinflammation, 24: 6-27.
- Brailoiu G.C., Dun S.L., Brailoiu E., Inan S., Yang J., Chang J.K., Dun N.J. (2007). Nesfatin-1: distribution and interaction witha Gprotein-coupled receptor in the rat brain. Endocrinology, 148: 5088-5094.
- Dockray G.J. (2009). The versatility of the vagus. Physiol. Behav., 97: 531-536.
- Druce M.R., Small C.J., Bloom S.R. (2004). Minireview: Gut peptides regulating satiety. Endocrinology, 145: 2660-2665.
- Duckert P., Brunak S., Blom N. (2004). Prediction of proprotein convertase cleavage sites. Protein Eng. Design. Select., 17: 107-112.
- Foo K.S., Brismar H., Broberger C. (2008). Distribution and neuropeptide coexistence of nucleobindin-2 m RNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience, 156: 563-579.
- Foo K.S., Brauner H., Ostenson C.G., Broberger C. (2010). Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycemic state. J. Endocrinol., 204: 255-263.
- Fort P., Salvert D., Hanriot L., Jego S., Shimizu H., Hashimoto K., Mori M., Lup- pi P.H. (2008). The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience, 155: 174-181.
- Gina L., Yosten C., Samson W.K. (2010). The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am. J. Physiol. Regul. Integr. Comp. Physiol., 298: 1642-1647.
- Goebel M., Stengel A., Wang L., Tach é Y. (2011). Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals. Peptides, 32: 36-43.
- Goebel - Stengel M., Wang L., Stengel A., Tach é Y. (2011). Localization of nesfatin-1 neurons in the mouse brain and functional implication. Brain Res., 1396: 20-34.
- Gonkowski S., Rychlik A., Nowicki M., Nieradka R., Bulc M., Ca łka J. (2012). Apopulation of nesfatin 1-like immunoreactive (LI) cells in the mucosal layer of the canine digestive tract. Res. Vet. Sci., http://dx.doi.org/10.1016/j.rvsc.2012.06.002.
- Gonzalez R., Reingold B.K., Gao X., Gaidhu M.P., Tsushima R.G., Unniappan S. (2011). Nesfatin-1 exertsadirect, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells. J. Endocrinol., 208: 9-16.
- Inhoff T., Stengel A., Peter L., Goebel M., Tach é Y., Bannert N., Wiedenmann B., Klapp B.F., M önnikes H., Kobelt P. (2010). Novel insight in distribution of nesfatin-1 and phospho-m TORin the arcuate nucleus of the hypothalamus of rats. Peptides, 31: 257-262.
- Iwasaki Y., Nakabayashi H., Kakei M., Shimizu H., Mori M., Yada T. (2009). Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem. Biophys. Res. Commun., 390: 958-962.
- Karabinos A., Bhattacharya D., Morys- Wortmann C., Kroll K., Hirschfeld G., Kratzin H.D., Barnikol - Watanabe S., Hilschmann N. (1996). The divergent domains of the NEFAand nucleobindin proteins are derived from an EF-hand ancestor. Mol. Biol. Evol., 13: 990-998.
- Maejima Y., Sedbazar U., Suyama S., Kohno D., Onaka T., Takano E., Yoshida N., Koike M., Uchiyama Y., Fujiwara K., Yashiro T., Horvath T.L., Dietrich M.O., Tanaka S., Dezaki K., Oh - I S., Hashimoto K., Shimizu H., Nakata M., Mori M., Yada T. (2009). Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia throughaleptin-independent melanocortin pathway. Cell Metab., 10: 355-365.
- Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. (2006). Central nervous system control of food intake and body weight. Nature, 443: 289-295.
- Nakata M., Manaka K., Yamamoto S., Mori M., Yada T. (2011). Nesfatin-1 enhances glucose- induced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet β-cells. Endocr. J., 58: 305-313.
- Oh - I S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yama - moto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Ya - mada M., Mori M. (2006). Identification of nesfatin-1 asasatiety molecule in the hypothalamus. Nature, 443: 709-712.
- Pa łasz A., Krzystanek M., Worthington J., Czajkowska B., Kostro K., Wiaderk- iewicz R., Bajor G. (2012). Nesfatin-1,aunique regulatory neuropeptide of the brain. Neuropeptides, 46: 105-112.
- Pan W., Hsuchou H., Kastin A.J. (2007). Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides, 28: 2223-2228.
- Price T.O., Samson W.K., Niehoff M.L., Banks W.A. (2007). Permeability of the blood-brain barrier toanovel satiety molecule nesfatin-1. Peptides, 28: 2372-2381.
- Price C.J., Samson W.K., Ferguson A.V. (2008). Nesfatin-1 inhibits NPYneurons in the arcuate nucleus. Brain Res., 1230: 99-106.
- Ramanjaneya M., Chen J., Brown J.E., Tripathi G., Hallschmid M., Patel S., Kern W., Hillhouse E.W., Lehnert H., Tan B.K., Randeva H.S. (2010). Identification of nesfatin-1 in human and murine adipose tissue:anovel depot-specific adipokine with increased levels in obesity. Endocrinology, 151: 3169-3180.
- Shimizu H., Oh - I S., Okada S., Mori M. (2009 a). Nesfatin-1: An overview and future clinical application. Endocrine J., 56: 537-543.
- Shimizu H., Oh - I S., Hashimoto K., Nakata M., Yamamoto S., Yoshida N., Egu- chi H., Kato I., Inoue K., Satoh T., Okada S., Yamada M., Yada T., Mori M. (2009 b). Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology, 150: 662-671.
- Shioda S., Takenoya F., Yagi M., Wang L., Hori Y., Kageyama H. (2008). Neural networks of several novel neuropeptides involved in feeding regulation. Nutrition, 24: 848-853.
- Simpson K.A., Martin N.M., Bloom S.R. (2009). Hypothalamic regulation of food intake and clinical therapeutic applications. Arq. Bras. Endocrinol., 53: 120-128.
- Stengel A., Goebel M., Yakubov I., Wang L., Witcher D., Coskun T., Tach é Y., Sachs G., Lambrecht N.W. (2008). Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology, 150: 232-238.
- Stengel A., Goebel M., Wang L., Rivier J., Kobelt P., M önnike H., Lam- brecht N.W., Tach é Y. (2009). Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology, 150: 4911-4919.
- Stengel A., Tach é Y. (2010). Nesfatin-1 - role as possible new potent regulator of food intake. Regul. Pept., 163: 18-23.
- Stengel A., Goebel - Stengel M., Jawien J., Kobelt P., Tach é Y., Lambrecht N.W. (2011). Lipopolysaccharide increases gastric and circulating NUCB2/nesfatin-1 concentrations in rats. Peptides, 32: 1942-1947.
- Su Y., Zhang J., Tang Y., Bi F., Liu J.N. (2010). The novel function of nesfatin-1: anti-hyperglycemia. Biochem. Biophys. Res. Commun., 391: 1039-1042.
- Zhang A.Q., Li XL., Jiang CY., Lin L., Shi RH., Chen J.D., Oomura Y. (2010). Expression of nesfatin-1/NUCB2 in rodent digestive system. World. J. Gastroenterol., 16: 1735-1741.